创新药已经走出低谷,民营医院还在底部徘徊。作为公立医疗的补充,民营医院的前景无限广阔,经过了野蛮生长阶段,大型民营医院基础已经夯实。众所周知,民营医院领域,做得最好的当数爱尔眼科以及通策医疗,爱尔眼科上市之后,其最高涨幅超过了百倍。但作为永续经营的行业,过快的并购容易给企业带来较大的商誉,一旦停止扩张对于企业的估值就会产生较大的影响。因此,不断地并购就成了民营医院的“解药”。但随着近两年投资的退潮...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.